Prognostic restaging after treatment initiation in patients with AL amyloidosis

The utility of systemic light chain (AL) amyloidosis staging systems has been validated for newly diagnosed patients, but their role in restaging after treatment has not been explored. We designed this study to evaluate whether the currently used systems are of prognostic value at 3 and 6 months of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Adv
Principais autores: Abdallah, Nadine, Dispenzieri, Angela, Muchtar, Eli, Buadi, Francis K., Kapoor, Prashant, Lacy, Martha Q., Hwa, Yi L., Fonder, Amie, Hobbs, Miriam A., Hayman, Suzanne R., Leung, Nelson, Dingli, David, Lust, John A., Go, Ronald S., Lin, Yi, Gonsalves, Wilson I., Kourelis, Taxiarchis, Warsame, Rahma, Kyle, Robert A., Rajkumar, S. Vincent, Gertz, Morie A., Kumar, Shaji K.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Hematology 2021
Assuntos:
Stimulus Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7903228/
https://ncbi.nlm.nih.gov/pubmed/33595624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020003782
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados